Ocrelizumab: FDA adverse event reports
61,983 FDA FAERS reports mention Ocrelizumab. 31,038 reports have a serious outcome flag.
Reported reactions
- Covid-19: 11,575 reports
- Fatigue: 6,244 reports
- Urinary Tract Infection: 3,783 reports
- Headache: 3,286 reports
- Multiple Sclerosis: 3,031 reports
- Multiple Sclerosis Relapse: 2,738 reports
- Gait Disturbance: 2,721 reports
- Asthenia: 2,713 reports
- Nasopharyngitis: 2,574 reports
- Pain: 2,563 reports
- Fall: 2,533 reports
- Off Label Use: 2,462 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.